Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNB1618 in Healthy Volunteers and PKU Patients
NCT03516487Phase 2Completed
- Sponsor
- Synlogic
- Start
- Apr 2018
- Primary completion
- Jun 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of SYNB1618 in phenylketonuria (PKU), sponsored by Synlogic. Started Apr 2018; status: completed.
02
Drugs
SYNB1618
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT03516487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516487.